Biotech news
Biotech
Evidence shows medicines approved as biosimilars in the EU may be prescribed interchangeably | Additional ‘switch’ studies no longer not need to be carried out. 22 September 2022
Biotech
Kansas-based company wins block on infringing plant-based albumins | Genetically programmed rice expresses human proteins used in immunotherapy drugs, gene therapies and vaccines. 15 September 2022
Biotech
Protecting new and inventive innovations in this increasingly crowded area is essential, explains Ine Vanderleyden of Mewburn Ellis. 23 August 2022
Americas
Japan-based pharma company must pay for infringment | Drug was recently approved for breast cancer treatment by EU. 21 July 2022
Americas
New partner boosts firm’s biotech practice | Move forms part of life sciences expansion | Role based at Washington, DC office. 19 July 2022
Pharma
BMS unit Juno Therapeutics and the Sloan Kettering Institute for Cancer Research have urged the US Supreme Court to reinstate their $1.2 billion win in a patent clash with Kite Pharma, a subsidiary of Gilead. 16 June 2022
Asia-Pacific
The Federal Court of Australia has refused an appeal request in a decade-long case brought by Boehringer Ingelheim Animal Health against MSD subsidiary, Intervet International. 24 May 2022
Biotech
The UK government will implement the Genetic Technology Bill which promises to “remove unnecessary barriers” inherited from the European Union to bolster gene-editing technology. 11 May 2022
Biotech
Canadian pharmaceutical company GlycoBioSciences has sued cosmetics giant L’Oreal, alleging that the French company’s anti-wrinkle products containing hyaluronic acid infringe two patents. 10 May 2022
Americas
Moderna has rejected claims that its COVID-19 vaccine violates the patent rights of two biopharma companies, arguing that its contract with the US federal government has conferred immunity. 10 May 2022